OmicsBank

Trusted Partner forAsian RWD&Multi-omics data access

OmicsBank provides robust, high-quality, longitudinal healthcare data and BioBank access from Asia, Africa, and the Middle East

Unlock patient RWE across Asia

OmicsBank provides robust, high-quality, de-identified, anonymised, longitudinal RWD and multi-omics data for AI and LLM models to drive advancements in drug development, R&D, and clinical trial optimisation.

Our platform ensures seamless integration of data in your system by API, prioritizing data anonymisation and full compliance with local and global regulatory standards.

Quality Longitudinal Data Captured in EMRs

Patient Visits Facility

EMR (Electronic Medical Records) Data covering demographics etc.

Diagnostics Tests

Blood/Tissue/CSF etc samples and Reports from LIMS (Lab Information Management System) and Biobank

Patient Management

Treatment Management from IPD/OPD notes and discharge summaries in EMR (Electronic Medical Records)

Patient Revisits Facility or End of Patient Management

Therapy Titration information through EMR or closure of therapy via discharge summaries

Types of Data

Clinical Data

ICD 9,10 and SNOMED-CT Standardised

1. Demographics 2. Diagnosis 3. Medical History 4. Surgical History 5. Tests and Reports 6. Doctor notes/Vitals

Genomics Data

FASTQ, GFF, GTF, SDF, MOL2, etc. Supported

1. Exome Geneomics Seq. 2. Whole Geneome Seq. 3. RNA Assay 4. DNA Assay 5. Proteomics

BioBank

Tissue Samples

1. Tissue Blocks 2. Cerebral Spinal Fluids

Imaging Data

De-identified/Pixel Removed .DICOM and Waveform Files

1. PET-CT 2. CT 3. MRI 4. Ultrasound 5. Echo 6. ECG

With OmicsBank You Can…

Get On-Demand Data Access

Instant access to vast datasets for rapid hypothesis testing and validation. Seamlessly integrate the data into AI/ML workflows, enhancing model training and validation.

Decrease cost of Drug Development

Reduced R&D costs by minimizing cost of RWD access through AI-driven drug discovery. Cut time-to-market and cost of drug development by 10 folds.

Revolutionise Drug Discovery Process

Enhanced predictive models, identification of novel drug candidates, and optimised clinical trials through the integration of high-quality RWD.

Manage Smoother and Predictable Regulatory Process

Strengthened regulatory submissions through comprehensive real-world evidence and post-market surveillance.

Contact

Connect With Us

Find us

169 Madison Avenue, STE 11133, New York, NY 10016, USA

Call us

+1 (203) 858-8646

Mail US

sam@omicsbank.com